Analysed BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) News Sources
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
05-10-2026
yahoo.com
BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?
15-10-2026
yahoo.com
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
21-10-2026
yahoo.com
BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
28-10-2026
yahoo.com
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
29-10-2026
yahoo.com
Wall Street Analysts See a 137.91% Upside in BioCryst (BCRX): Can the Stock Really Move This High?
30-10-2026
yahoo.com
What is the current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The current price of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is $8.47.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is $-0.05.
BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) since the previous trading day is -0.5869%.
What is the most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent average sentiment score for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)?
The most recent sentiment for BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ) is .
SEC-8K** Filing Available For BIOCRYST PHARMACEUTICALS INC (BCRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.